As the overexpression of the EphB2-ephrinB2 complex is associated with these cancers, further analysis for drug discovery could aid in identifying possible new hotspots that potentially aid in drug discovery in the fight against cancer (Barquilla & Pasquale, 2015). Here, EFNB2 is linked to cancer.